D. Ackermann

Ackermann is joining Oyster Point Pharma as Chairman of the Board. Previously, he was Vice President of Neurostimulation at Allergan and was President and CEO of Oculeve, Inc. He has twelve years of experience in medical technology development in both academic and industrial settings in the fields of ophthalmology, chronic pain and movement disorders. He has numerous patents and peer-reviewed publications